Nathalie Adda
2017
In 2017, Nathalie Adda earned a total compensation of $1.8M as Senior Vice President, Chief Medical Officer at Enanta Pharmaceuticals, a 73% increase compared to previous year.
Compensation breakdown
| Bonus | $117,016 |
|---|---|
| Non-Equity Incentive Plan | $48,617 |
| Option Awards | $599,585 |
| Salary | $400,313 |
| Stock Awards | $574,369 |
| Other | $18,551 |
| Total | $1,758,451 |
Adda received $599.6K in option awards, accounting for 34% of the total pay in 2017.
Adda also received $117K in bonus, $48.6K in non-equity incentive plan, $400.3K in salary, $574.4K in stock awards and $18.6K in other compensation.
Rankings
In 2017, Nathalie Adda's compensation ranked 6,146th out of 14,666 executives tracked by ExecPay. In other words, Adda earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,146 out of 14,666 | 58th |
Division Manufacturing | 2,256 out of 5,770 | 61st |
Major group Chemicals And Allied Products | 712 out of 2,074 | 66th |
Industry group Drugs | 549 out of 1,730 | 68th |
Industry Pharmaceutical Preparations | 431 out of 1,329 | 68th |
Source: SEC filing on January 19, 2018.
Adda's colleagues
We found four more compensation records of executives who worked with Nathalie Adda at Enanta Pharmaceuticals in 2017.